Although further studies are required to confirm, it is plausible that IRAP inhibition post-stroke increases monocyte recruitment through elevated CCL2 and therefore promotes M2 polarisation, or that direct IRAP inhibition preferentially differentiates monocyte/microglia M2 phenotype via an alternative mechanism. The gene discussed is CCL2; the disease is stroke disorder.